Extends Uninterrupted Support for FSC 5962 Microcircuits

STONY BROOK, N.Y. (November 20, 2017) – Applied DNA Sciences, Inc. (NASDAQ: APDN; “Applied DNA”) today announced that the Defense Logistics Agency (DLA) has awarded the Company a one-year extension of its current contract through October 13, 2018. This agreement maintains consistent support of the DNA marking lab originally established December 2014 at DLA’s Land and Maritime facility in Columbus, OH. With a focus on Federal Supply Class 5962 microcircuits, Applied DNA provides DLA’s Electronic Product Test Center (PTC) with full support including creation of SigNature® DNA marks, related equipment and supplies, services and continuous improvement.

“My team and I are proud to be part of Land and Maritime’s strategic initiative to identify and manage supply-system risks with the use of innovative DNA technology that can be inserted into DLA acquisition programs to meet specific defense needs. To date, over 800,000 microcircuits have been DNA marked,” stated Janice Meraglia, vice president of Government and Military Programs at Applied DNA. “It is an honor to continue to work with the PTC team in Columbus to keep our Warfighters safe.”

About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics.

We make life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based “CertainT®” platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products.

SigNature® DNA describes the core technology ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature®T and fiberTyping®, targeted towards textiles and apparel, BackTrac™ and DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track-and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

Forward-Looking Statements
The statements made by APDN in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 6, 2016, and our subsequent quarterly reports on Form 10-Q filed on February 9, 2017, May 11, 2017 and August 10, 2017  which are available at www.sec.gov. APDN , undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

Contacts
investor contact: Sanjay Hurry, 212-838-3777, shurry@lhai.com
Media: Cheryl Schneider, Dian Griesel Int’l, 212-825-3210, cschneider@dgicomm.com
Program Contact: Janice Meraglia, 631-240-8821, janice.meraglia@adnas.com
web: www.adnas.com, twitter: @APDN

New patents protect SigNature T molecular tagging technology and a multimode reader device enabling IT integrated instant authentication 

STONY BROOK, N.Y. (November 3, 2017) – Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ: APDN) is pleased to announce the issuance of U.S. Patent No. 9,790,538 (US 2014/0256881) entitled “Alkaline Activation for Immobilization of DNA Taggants” and a Notice of Allowance of U.S. Patent Application 15/027,454 (US 2016/0246892) entitled “Multimode Image and Spectral Reader.”

The ‘538 patent, issued on October 17, 2017, protects the core technology powering Applied DNA’s SigNature T molecular tags in the textile industry and is directed at methods of enhancing the binding affinity of molecular tags to a variety of textile substrates, including cotton, wool, cellulosic materials and man-made fibers. The enhanced binding affinity of the SigNature T molecular tags enables them to survive extremely harsh manufacturing processes, such as those found in leather, cotton and synthetics manufacturing. The patented methods are currently used in wide range of SigNature T applications, and are integral to the Company’s pursuit of a global textile industry anticipated to grow to $910 billion in sales in 2019 from $750 billion in 2015*.

The ‘454 Application, allowed on October 26, 2017 will issue as a patent, and protects Applied DNA’s proprietary Multimode Image and Spectral Reader (“MMR”) device that provides for instant detection and identification of a wide variety of optical, molecular, olfactory and radio based taggants through the use of electronic sensor capture and digital database analysis. The handheld MMR device can rapidly detect one or more taggants and compare the detected taggants to library of known taggant configurations to provide instant authentication.

“We take great pride in the patenting of our SigNature T molecular tags, providing us with broad long-term market exclusivity. In addition, the patenting of our MMR device paves the way for the instant authentication of a broad range of taggants and exciting licensing opportunities,” said Dr. James Hayward, president and CEO of Applied DNA.  “Protecting our innovations has always been a cornerstone of Applied DNA. Our robust intellectual property portfolio is more important than ever, as industry awareness and acceptance of our technologies is rapidly growing.”The issuance of the ‘538 patent raises Applied DNA’s patent portfolio to 53, in addition to over 70 pending applications.*Work Textile Information Network’s ‘World Textile Outlook 2016’ (click for free report).To learn more about Applied DNA visit www.adnas.com.

About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics.We make life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based “CertainT®” platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products.SigNature® DNA describes the core technology ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature®T and fiberTyping®, targeted towards textiles and apparel, BackTrac™ and DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track-and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

Forward-Looking Statements
The statements made by APDN in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 6, 2016, and our subsequent quarterly reports on Form 10-Q filed on February 9, 2017, May 11, 2017 and August 10, 2017  which are available at www.sec.gov. APDN , undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

Contacts
investor contact: Sanjay Hurry, 212-838-3777, shurry@lhai.com
media contact: Angie Mathews, 781-639-4924, angie@cgprpublicrelations.com
program contact: MeiLin Wan, 631-240-8849, meilin.wan@adnas.com
web: www.adnas.com, twitter: @APDN

CertainT Tag-Test-Track System at the Synthetic Yarn Fiber Association on October 27, 2017 in Charlotte, North Carolina 

STONY BROOK, N.Y. (October 24, 2017) – Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ: APDN), has signed a new CertainT^® trademark license agreement with Palmetto Synthetics (“Palmetto”), a leader in the production of high quality, specialty synthetic fiber. Palmetto’s mission “is to be the leading global innovator and provider of specialty synthetic fiber while fostering a culture of integrity, dignity and respect for their team members, business partner, community and environment.” The newly signed CertainT trademark licensing agreement enables Palmetto to reach their goals of bringing transparency to their own manufacturing processes, and also to provide their customers with traceability and trust in the original tagged synthetic fiber.

Under the CertainT^® platform, customers are provided with secure, forensic guidelines for monitoring the flow of product through the manufacturing process via molecular tagging, testing and tracking. Routine inspection and authentication is transparent and certified throughout the process via an integrated database and portal. CertainT also helps customers with meeting their sustainability goals by 2020. Products that use recycled, renewable or re-usable materials that have an eco-conscious composition can benefit from molecular tagging.

David Poston, President of Palmetto Synthetics stated “that to continue to be an industry leader, one must embrace new technology in paving the way to commit to customer excellence through the promotion of state of the art technology. As indicated in the past, we have our eye on the future and we are excited about CertainT’s platform and look forward to total implementation.”

“The CertainT system physically traces the raw material, ingredient, component and product, so you can claim that you are performing full traceability from source to shelf. That’s the difference between most standards that certify products that use a paper trail, or a mass-balance approach, where certified raw materials, such as recycled PET can be easily mixed with non-certified ones. CertainT can help assure product integrity and traceability by ensuring the product itself,” stated Dr. James A. Hayward, President and CEO of Applied DNA Sciences.

Applied DNA Sciences and Palmetto Synthetics will be co-presenting with Techmer PM at the Synthetic Yarn Fibers Association Fall Conference in Charlotte, North Carolina in October 27, 2017.

About Palmetto Synthetics
Palmetto Synthetics, headquartered in Kingstree, SC, is a provider of custom design solutions in the world of synthetic fiber. They offer a wide range of polymers that can be spun into fiber for such end uses as footwear, performance apparel, geotextiles fabrics for erosion control, roofing products and filtration media. They also are heavily engaged in post-consumer recycled fibers for a variety of applications.

About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics.

We make life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based “CertainT®” platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products.

SigNature® DNA describes the core technology ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature®T and fiberTyping®, targeted towards textiles and apparel, BackTrac™ and DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track-and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

Forward-Looking Statements
The statements made by APDN in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 6, 2016, and our subsequent quarterly reports on Form 10-Q filed on February 9, 2017, May 11, 2017 and August 10, 2017  which are available at www.sec.gov. APDN , undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

Contacts
investor contact: Sanjay Hurry, 212-838-3777, shurry@lhai.com
media contact: Angie Mathews, 781-639-4924, angie@cgprpublicrelations.com
program contact: MeiLin Wan, 631-240-8849, meilin.wan@adnas.com
web: www.adnas.com, twitter: @APDN

Tag-Test-Track Masterbatch Systems to be Unveiled at the Synthetic Yarn Fiber Association on October 27, 2017

STONY BROOK, N.Y. (October 23, 2017) – Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ: APDN), has signed a new CertainT® trademark license agreement with Techmer PM (“Techmer”), a respected producer of value added colors and additives for the plastic and fiber industries, and a long standing customer of Applied DNA’s SigNature® T molecular tags. Techmer’s mission is to provide its customers with the best technical support in “problem solving designs for modifying the properties of base polymers.” In the complex world of sustainability, Techmer has embraced Applied DNA’s CertainT platform as a means to prove sustainable sources and ensure product integrity and supply chain transparency.“

Masterbatches” are concentrated additives used to impart qualities or colors to compounded plastics. With the implementation of the CertainT trademark on its SigNature T molecularly tagged PET or recycled PET masterbatch, Techmer is now able to illustrate to its customers, potential customers and downstream supply chain partners the ability to forensically interrogate its high quality source material in all phases of the manufacturing process – from source masterbatch pellet to the end product, allowing Techmer to differentiate itself in a dynamic market.

John Manuck, CEO, Chairman and founder of Techmer stated, “Innovation through collaboration enables our company to partner with state of the art companies such as Applied DNA. A successful 21st century company must be adept at applying new technology through the supply train.  Leveraging new ideas and applying design concepts are vital to future growth. Customers want to know where their products were designed and manufactured, and we want to be at the forefront in reliably providing that information.”

“Our new CertainT collaboration with Techmer through increased use of our tag in their masterbatch programs will immediately help their customers,” said Dr. James Hayward, President and CEO of Applied DNA. “By expanding our existing relationship to include trademark licensing, Techmer highlights the growing awareness and adoption of our CertainT platform with a public-facing trademark that stands for authenticity, transparency and performance.”

Applied DNA Sciences and Techmer will be co-presenting at the Synthetic Yarn Fibers Association Fall Conference in Charlotte, North Carolina on October 27, 2017.

About Techmer PM
Techmer PM, LLC, headquartered in Clinton, Tennessee, is a major producer of value-added masterbatch and engineered compounds for the plastics and fiber industries. The company manufactures and sells masterbatch under its Techmer PM brand and engineered thermoplastic compounds through its Techmer ES subsidiary. The company has worldwide manufacturing capabilities focusing on high-performance applications where quality, technical support, and problem solving are critical. Techmer PM was recently recognized by Plastics News on its “Best Places to Work 2014” list. Learn more about the company by visiting techmerpm.com.

About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics.

We make life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based “CertainT®” platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products.

SigNature® DNA describes the core technology ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature®T and fiberTyping®, targeted towards textiles and apparel, BackTrac™ and DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track-and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

Forward-Looking Statements
The statements made by APDN in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 6, 2016, and our subsequent quarterly reports on Form 10-Q filed on February 9, 2017, May 11, 2017 and August 10, 2017  which are available at www.sec.gov. APDN , undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

Contacts
investor contact: Sanjay Hurry, 212-838-3777, shurry@lhai.com
media contact: Angie Mathews, 781-639-4924, angie@cgprpublicrelations.com
program contact: MeiLin Wan, 631-240-8849, meilin.wan@adnas.com
web: www.adnas.com, twitter: @APDN

Product designers from around the world have access to and learn about SigNature T to embed into their products

STONY BROOK N.Y. October 19, 2017 – Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ: APDN) today announced that its SigNature molecular tag technology has been inducted into Material ConneXion’s prestigious library of innovative materials. Visitors to the library’s branches throughout the world will now have access to Applied DNA’s technologies. A tabula of the technology will be on display in the libraries and accessible through the Material ConneXion online directory database. Material ConneXion, a global materials consultancy, helps companies to leverage material innovation to create better products and experiences.

“New sciences and technologies are evaluated and selected for inclusion based on their unique offerings, cutting-edge innovation and outstanding performance,” said Kerrie Rosenheck, material specialist with Material ConneXion. “Applied DNA’s molecular tagging platform is a powerful tool with which to authenticate products throughout the global supply chain and to ensure they are truthfully labeled.”

Upon assessment by a panel of experts in the materials field, SigNature molecular tagging was selected. With material libraries in: Bangkok, Thailand; Bilbao, Spain; Daegu, South Korea; Milan, Italy; Skövde, Sweden; Tokyo, Japan; and New York City, SigNature molecular tagging advancements in textile tracking and authentication will be an important part of the solutions for tackling product claims and authenticity challenges.

“Our inclusion into the Library is a testament to our success to date in purifying the cotton supply chain and reflects the growing strategic role that technologies such as ours are establishing with supply chain participants to power their sustainability and consumer assurance goals,” said Dr. James Hayward, Applied DNA president and CEO.

Designers interested in learning more about how the platform enhances their specific use case may meet with Applied DNA at its facility in Stony Brook, New York, equipped with a demonstration room and full forensic laboratories.

Material ConneXion is a trusted advisory body to Fortune 500 companies, global agencies and government bodies seeking a creative, competitive and sustainable advantage. Material ConneXion is built on the belief that Every Idea has a Material Solution™. It is a trusted partner of Fortune 500 corporations and forward-thinking companies seeking a sustainable or competitive edge.

About Material ConneXion
Material ConneXion is made up of an international team of multidisciplinary experts that bridge the gap between science and design to create practical manufacturing solutions. Widely regarded an authority on materials, and as the leading global platform for material solutions and innovations, the Material ConneXion team includes Ph.D. material scientists and material specialists with cross-industry work experience at Fortune 500s and national laboratories.

About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics.

We make life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based “CertainT™” platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products.

SigNature® DNA describes the core technology ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature®T and fiberTyping®, targeted towards textiles and apparel, BackTrac™ and DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track-and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

Forward-Looking Statements
The statements made by APDN in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 6, 2016, and our subsequent quarterly reports on Form 10-Q filed on February 9, 2017, May 11, 2017 and August 10, 2017  which are available at www.sec.gov. APDN , undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

Contacts
investor contact: Sanjay Hurry, 212-838-3777, shurry@lhai.com
media contact: Angie Mathews, 781-639-4924, angie@cgprpublicrelations.com
program contact: MeiLin Wan, 631-240-8849, meilin.wan@adnas.com
web: www.adnas.com, twitter: @APDN

Partnership enables brands that use inkjet to forensically tag products and packaging, test throughout the supply chain, and track globally to certify product claims, and prevent diversion and counterfeits

STONY BROOK, N.Y. September 26, 2017 – Applied DNA Sciences, Inc. (“Applied DNA,” “the company,” NASDAQ: APDN), has entered into a strategic partnership with VideojetTechnologies (Videojet). Applied DNA and Videojet have collaborated in the design of co-branded Applied DNA SigNature® molecular-tagged Videojet inks, and a co-branded printer that electronically restricts the use of ink cartridges to only those that contain SigNature DNA inks. The relationship brings the potential to empower the tagging of countless commercial items, all of which are candidates for a CertainT™ licensing agreement, enabling traceability along the entire supply chain. These solutions will be jointly introduced this week at Pack Expo 2017 in Las Vegas, NV.

Integrating the technologies from both companies creates a world-class solution that will be offered to the many industries in which both companies are already engaged. Videojet’s 325,000-install base of printers, which code and mark well over ten billion products each day, is a testament to the power of continuous inkjet printing (CIJ) technology. The initial offering utilizes Videojet’s newly released 1860 printer, which will be co-branded with Applied DNA, along with co-branded Videojet inks that will incorporate Applied DNA’s unique SigNature molecular tag into each individual ink cartridge. The SigNature-enabled inks will be brand-specific, enabling each brand to tag, test and track their products from source to shelf under a CertainT platform. Gaining this additional traceability, transparency, and ultimately trust between value chain partners will allow brands to offer a new level of certainty to their customers that the products they are buying are authentic.

The initial rollout of co-branded SigNature molecular tagged inks includes an aerospace-approved ink. This durable black ink was chosen to qualify first, due to its specific application and use in US military and aerospace industry for unique identifier (UID) tags for an array of critical components spanning several Federal Supply Groups (FSGs). Initial qualification testing, confirming that the molecular tagged ink does not impact printer uptime or operation, was performed under Applied DNA’s first Rapid Innovation Fund (RIF) contract awarded by the Office of the Secretary of Defense. In addition to critical FSG items, this ink is most commonly used as a date/lot code marking solution for food, tobacco, coffee, baby, health and personal care.

“We are very excited to team with Videojet to bring this combined solution to market and offer a broad range of companies a definitive method to support their brand protection strategies. This is a significant opportunity to increase the universe of SigNature-tagged items, increase our market share, and broadly secure the supply chains of complex commercial ecosystems through the use of our CertainT platform,” stated Dr. James Hayward, President and CEO of Applied DNA.

“Applied DNA’s SigNature molecular tags and CertainT platform complements Videojet’s marking and coding solutions, allowing us to offer a new secure ink option, adding to our robust portfolio of brand protection and industrial track and trace offerings that are used across many commercial industries,” said Fred Susi, Videojet VP of Business and Product Planning.

About Videojet Technologies
Videojet Technologies is a world-leader in the product identification market, providing in-line printing, coding, and marking products, application specific fluids, and product life cycle services. Our goal is to partner with our customers in the consumer packaged goods, pharmaceutical, and industrial goods industries to improve their productivity, to help protect and grow their brands, and to stay ahead of industry trends and regulations. With our customer application experts and technology leadership in continuous inkjet (CIJ), thermal inkjet (TIJ), laser marking, thermal transfer overprinting (TTO), case coding and labeling, and wide array printing, Videojet has more than 345,000 printers installed worldwide. Our customers rely on Videojet products to print on over ten billion products daily. Customer sales, application, service, and training support is provided by direct operations with over 4,000 team members in 26 countries worldwide. In addition, the Videojet distribution network includes more than 400 distributors and OEMs, serving 135 countries.

About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics.

We make life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based “CertainT™” platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products.

SigNature^® DNA describes the core technology ingredient that is at the heart of a family of uncopiable, security and authentication solutions such as SigNature^® T and fiberTyping^®, targeted toward textiles and apparel, BackTrac™ and DNAnet^®, for anti-theft and loss prevention, and digitalDNA^®, providing powerful track-and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

The Company’s common stock is listed on NASDAQ under the symbol APDN, and its warrants are listed under the symbol APDNW.

Forward Looking Statements
The statements made by APDN in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 6, 2016, and our subsequent quarterly reports on Form 10-Q filed on February 9, 2017, May 11, 2017 and August 10, 2017, which are available at www.sec.gov. APDN, undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

Investor contact: Sanjay M. Hurry, LHA Investor Relations, 212-838-3777, shurry@lhai.com
Media: Susan Forman, Dian Griesel Int’l, 212-825-3210, sforman@dgicomm.com
Program Contact: Janice Meraglia, 631-240-8821, janice.meraglia@adnas.com
web: www.adnas.com
twitter: @APDN

STONY BROOK, N.Y. September 21, 2017 – Applied DNA Sciences, Inc. (NASDAQ: APDN), announced that Dr. James Hayward, president & CEO, will present at the 2017 Disruptive Growth Company Showcase at the Grand Hyatt in New York City on Wednesday, September 27 at 2:30 p.m. ET. Dr. Hayward will present to an audience of investors and industry professionals and will be available for one-on-one meetings with institutional investors.Dr. Hayward’s presentation at the Showcase will also be webcast through the Investor Relations section of the company’s website at www.adnas.com.

About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics.

We make life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based “CertainT™” platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products.

SigNature^® DNA describes the core technology ingredient that is at the heart of a family of uncopiable, security and authentication solutions such as SigNature^® T and fiberTyping^®, targeted toward textiles and apparel, BackTrac™ and DNAnet^®, for anti-theft and loss prevention, and digitalDNA^®, providing powerful track-and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

The Company’s common stock is listed on NASDAQ under the symbol APDN, and its warrants are listed under the symbol APDNW.

Forward Looking Statements
The statements made by APDN in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 6, 2016, and our subsequent quarterly reports on Form 10-Q filed on February 9, 2017, May 11, 2017 and August 10, 2017, which are available at www.sec.gov. APDN, undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

Investor contact: Sanjay M. Hurry, LHA Investor Relations, 212-838-3777
web: www.adnas.com
twitter: @APDN

STONY BROOK N.Y. (September 18, 2017) – Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ: APDN), today announced that it has filed a Registration Statement with the Securities and Exchange Commission (the “Registration Statement”) with respect to the sale by certain selling security holders of common stock to be received upon exercise of warrants previously sold by the Company in 2014. The Registration Statement is being filed to update a registration statement originally filed in 2014. The warrants to purchase 3,215,590 shares have an exercise price of $3.50 and are listed on NASDAQ under the symbol APDNW. In addition, the Registration Statement relates to the sale of common stock to be received by certain selling security holders upon the exercise of warrants sold to investors in a private placement in 2015 and issued to placement agents and underwriters of various offerings by the Company in 2011, 2014, 2015 and 2016. These warrants to purchase an aggregate of 1,727,630 shares have exercise prices ranging from $2.53 to $4.30.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any offer or sale of these securities in any state or jurisdiction in which an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. When available, a written prospectus may be obtained from Applied DNA Sciences, Inc. at 50 Health Sciences Drive, Stony Brook, New York 11790, Attn: Beth Jantzen.

About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics.

We make life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based “CertainT™” platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products.

SigNature^® DNA describes the core technology ingredient that is at the heart of a family of uncopiable, security and authentication solutions such as SigNature^® T and fiberTyping^®, targeted toward textiles and apparel, BackTrac™ and DNAnet^®, for anti-theft and loss prevention, and digitalDNA^®, providing powerful track-and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

The Company’s common stock is listed on NASDAQ under the symbol APDN, and its warrants are listed under the symbol APDNW.

Forward Looking Statements
The statements made by APDN in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 6, 2016, and our subsequent quarterly reports on Form 10-Q filed on February 9, 2017, May 11, 2017 and August 10, 2017, which are available at www.sec.gov. APDN, undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

Investor contact: Sanjay M. Hurry, LHA Investor Relations, 212-838-3777
web: www.adnas.com
twitter: @APDN

CRADA Awarded Under Recent Rapid Innovation Fund Contract; Project to Demonstrate Hand-held DNA Detection Kits to Drive Adoption of DNA-based Supply Chain Security

STONY BROOK, N.Y. September 12, 2017 – Applied DNA Sciences, Inc. (“Applied DNA”, “the Company”, NASDAQ: APDN), is proud to announce the signing of a Cooperative Research and Development Agreement (“CRADA”) with the U.S. Army Research, Development and Engineering Command’s Edgewood Chemical Biological Center (“ECBC”) to study the commercialization of ECBC’s innovative rapid, in-field DNA microarray technology for use in military and commercial supply chains. ECBC is the nation’s primary Department of Defense (“DoD”) technical research organization for non-medical chemical and biological warfare defense.

Under the terms of the CRADA, a cooperative effort under the recently-announced Defense Logistics Agency Rapid Innovation Fund award secured by Applied DNA in June 2017, ECBC’s subject matter experts and Applied DNA’s science team will cooperatively study the feasibility of commercializing ECBC’s in-field DNA detection technology in varied supply chains. ECBC’s hand-held in-field DNA microarray technology allows for detection of a DNA taggant within a few minutes. The project goal is to demonstrate the system with Applied DNA’s taggants introduced into standard inks or varnishes or onto other surfaces, without the need for DNA amplification or other sample preparation, thus greatly simplifying in-field DNA detection.

“Rapid, hand-held in-field DNA detection has long been a goal of ours and is essential to the long-term growth of our technology platform,” stated Dr. James Hayward, president and CEO of Applied DNA. “We are honored to work with the U.S. Army through ECBC to study the commercialization of the ECBC’s innovative in-field DNA detection technology as a complement to our DNA authentication products for supply chain integrity capable of rapid detection anywhere, anytime, for global supply chains.”

Continued Dr. Hayward, “This mutually beneficial cooperative research and development project parallels our ongoing partnership with several DoD agencies and reflects our continued efforts to commercialize technologies made available under our ongoing DoD R&D contracts. We believe that the ECBC’s technology is extremely promising in this regard and are excited to work alongside it on this next generation data capture.”

About the U.S. Army Research, Development and Engineering Command’s Edgewood Chemical Biological Center
ECBC possesses an unrivaled chemical biological research and development infrastructure with scientists, engineers, technicians and specialists located at four different sites in the United States: Edgewood Area of Aberdeen Proving Ground, Md., Pine Bluff, Ark., Rock Island, Ill., and Dugway Proving Ground, Utah.ECBC has a unique role in technology development that cannot be duplicated by private industry or research universities. It fosters research, development, testing, and application of technologies for protecting warfighters, first responders and the nation from chemical and biological warfare agents. ECBC is currently developing better ways to remotely detect these chemical and biological materials – before the warfighter or first responder ever enters the threat zone. ECBC is also developing a new generation of technologies to counter everything from homemade explosives to biological aerosols to traditional and non-traditional chemical hazards.

About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics.

We make life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based “CertainT™” platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products.

SigNature^® DNA describes the core technology ingredient that is at the heart of a family of uncopiable, security and authentication solutions such as SigNature^® T and fiberTyping^®, targeted toward textiles and apparel, BackTrac™ and DNAnet^®, for anti-theft and loss prevention, and digitalDNA^®, providing powerful track-and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

The Company’s common stock is listed on NASDAQ under the symbol APDN, and its warrants are listed under the symbol APDNW.

Forward Looking Statements
The statements made by APDN in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 6, 2016, and our subsequent quarterly reports on Form 10-Q filed on February 9, 2017, May 11, 2017 and August 10, 2017, which are available at www.sec.gov. APDN, undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

Investor contact: Sanjay M. Hurry, LHA Investor Relations, 212-838-3777, shurry@lhai.com
Media: Susan Forman, Dian Griesel Int’l, 212-825-3210, sforman@dgicomm.com
Program Contact: Janice Meraglia, 631-240-8821, janice.meraglia@adnas.com
web: www.adnas.com
twitter: @APDN